Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/04/2013EP2634185A1 TYK2 kinase inhibitors
09/04/2013EP2634184A1 C-arylglucoside derivative, preparation method therefor, and use thereof
09/04/2013EP2634178A1 Quinazoline derivative and quinazoline complex protein kinase inhibitor for inhibiting multiplication of tumor cells and preparation method thereof
09/04/2013EP2634177A1 Tau imaging probe
09/04/2013EP2634176A1 Pyridine derivative and medicinal agent
09/04/2013EP2634173A1 Polymorph of n-(6-(4-chlorophenoxy)hexyl)-n'-cyano-n''-(4-pyridyl)guanidine, and preparation therefor and use thereof
09/04/2013EP2634171A1 23-yne-vitamin d3 derivative
09/04/2013EP2633886A1 Compounds and mixtures influencing inflammatory states
09/04/2013EP2633885A1 Compounds and mixtures for affecting inflammatory conditions
09/04/2013EP2633884A1 Obesity small molecules
09/04/2013EP2633859A1 Use of biological surfactant as anti-inflammatory agent and tissue preservative solution
09/04/2013EP2633858A2 Small molecules that replace or agonize p53 function
09/04/2013EP2633857A1 Solid pharmaceutical dosage form of ticagrelor and acetylsalicylic acid
09/04/2013EP2633856A2 ATP citrate lyase inhibitors for treating cancer
09/04/2013EP2633855A1 Protease inhibitors for treating Trichomonas gallinae infections
09/04/2013EP2633854A1 miRNA-9 or miRNA-9* for use in treating MND
09/04/2013EP2633853A1 Long-term delivery formulations and methods of use thereof
09/04/2013EP2633053A1 Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
09/04/2013EP2633052A2 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
09/04/2013EP2633050A1 Method of treatment based on atad2 inhibitors
09/04/2013EP2633049A2 Methods and compositions to protect aquatic invertebrates from disease
09/04/2013EP2632937A1 Peptide
09/04/2013EP2632933A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
09/04/2013EP2632927A1 Boronates as arginase inhibitors
09/04/2013EP2632926A1 Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii
09/04/2013EP2632925A1 N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS
09/04/2013EP2632924A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
09/04/2013EP2632923A1 Quinazoline derivatives
09/04/2013EP2632921A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl]methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
09/04/2013EP2632919A2 Pyrazole compounds
09/04/2013EP2632918A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
09/04/2013EP2632916A1 Novel anti-cancer agents
09/04/2013EP2632915A1 Benzimidazole inhibitors of leukotriene production
09/04/2013EP2632912A2 Anti-cancer serine hydrolase inhibitory carbamates
09/04/2013EP2632908A1 Sulfonamides as hiv protease inhibitors
09/04/2013EP2632906A1 Oxazoline and isoxazoline derivatives as crac modulators
09/04/2013EP2632903A2 Metalloenzyme inhibitor compounds
09/04/2013EP2632900A2 Caprolactam mglur5 receptor modulators
09/04/2013EP2632899A1 Substituted phenoxypyridines
09/04/2013EP2632895A1 Hiv protease inhibitors
09/04/2013EP2632892A1 Diterpenoid derivatives endowed of biological properties
09/04/2013EP2632885A1 Phenylketone carboxylate compounds and pharmaceutical uses thereof
09/04/2013EP2632552A1 Inhibition of microbial growth by aconitase inhibition
09/04/2013EP2632491A2 Enhanced cancer treatment and monitoring using recombinant vectors
09/04/2013EP2632487A2 Viral vaccine and process for preparing the same
09/04/2013EP2632471A2 Trimegestone (tmg) for treatment of preterm birth
09/04/2013EP2632470A2 Personal care compositions comprising a pyrithione and an iron chelator
09/04/2013EP2632469A2 Tricyclic mglur5 receptor modulators
09/04/2013EP2632468A1 Therapeutic compositions for diabetic symmetrical polyneuropathy
09/04/2013EP2632467A1 Cdk inhibitors
09/04/2013EP2632466A2 Quinazoline derivatives, compositions, and uses related thereto
09/04/2013EP2632465A1 Inhibitors of the renal outer medullary potassium channel
09/04/2013EP2632464A1 Inhibitors of the renal outer medullary potassium channel
09/04/2013EP2632463A2 Aripiprazole compositions and methods for its transdermal delivery
09/04/2013EP2632462A1 Novel heteroaryl-carboxamide derivatives as pdk1 inhibitors
09/04/2013EP2632461A1 Isoindolinone pde10 inhibitors
09/04/2013EP2632460A2 Compositions and methods for treating tuberculosis
09/04/2013EP2632459A2 Method of treating neuroendocrine tumors
09/04/2013EP2632458A1 Dosing regimes for the treatment of ocular vascular disease
09/04/2013EP2632457A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
09/04/2013EP2632456A1 Composition and method for influencing energy metabolism and treating metabolic and other disorders
09/04/2013EP2632455A1 Ophthalmic compositions
09/04/2013EP2632454A1 Hiv integrase inhibitors
09/04/2013EP2632453A1 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation
09/04/2013EP2632452A1 Compounds and compositions for the treatment of cancer
09/04/2013EP2632451A2 Use of malononitrilamides in neuropathic pain
09/04/2013EP2632450A1 Compositions comprising a taxane for coating medical devices
09/04/2013EP2632449A1 Treatment of ocular and cerebral ischemia
09/04/2013EP2632448A1 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
09/04/2013EP2632447A1 A process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing
09/04/2013EP2632446A1 Treatment for dupuytren's disease
09/04/2013EP2632445A1 Novel drug target site within gp120 of hiv
09/04/2013EP2632444A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS
09/04/2013EP2632442A2 Formulations and methods for attenuating respiratory depression induced by opioid overdose
09/04/2013EP2632439A1 Pharmaceutical formulations of a substituted diaminopurine
09/04/2013EP2632438A1 Multilayer pharmaceutical composition comprising telmisartan and amlodipine
09/04/2013EP2632437A2 Ternary mixture formulations
09/04/2013EP2632436A1 Solid dispersions containing an apoptosis-inducing agent
09/04/2013EP2632435A1 Liposomal drug composition containing a polymeric guanidine derivative
09/04/2013EP2632432A2 Composition and method for treating wounds
09/04/2013EP2632431A1 Inflammatory disease
09/04/2013EP2632430A1 Nasal compositions of vitamin b12
09/04/2013EP2632429A1 Oral pharmaceutical film formulation for bitter-tasting drugs
09/04/2013EP2632427A1 Ophthalmic composition
09/04/2013EP2632270A1 Polymorphs of febuxostat
09/04/2013EP2632269A1 Cyclic amine substituted oxazolidinone cetp inhibitor
09/04/2013EP2632268A2 Novel compounds that are erk inhibitors
09/04/2013EP2632264A2 Novel formulations of water-insoluble chemical compounds and methods of using a formulation of compound fl118 for cancer therapy
09/04/2013EP2632263A1 Novel thiazole-carboxamide derivatives as pdk1 inhibitors
09/04/2013EP2632261A1 Inhibitors of hepatitis c virus
09/04/2013EP2632260A1 Leucine-rich repeat kinase enzyme activity
09/04/2013EP2632259A1 Hypersulfated disaccharides to treat elastase related disorders
09/04/2013EP2632256A1 Fatty amides and derivatives from natural oil metathesis
09/04/2013EP2632255A1 Diazeniumdiolate heterocyclic derivatives
09/04/2013EP2632254A2 Deuterium enriched rasagiline
09/04/2013EP2632253A1 Process for the preparation of an orexin receptor antagonist
09/04/2013EP2374798B1 Benzazepine derivatives useful as vasopressin antagonists
09/04/2013EP1997478B1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
09/04/2013CN1774238B Formulations and methods for treating rhinosinusitis
09/04/2013CN1685227B Bioequivalence test for iron-containing formulations
1 ... 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 ... 7860